Marla Beck is departing BeautyHealth, owner of Hydrafacial.

She will be succeeded as president and chief executive officer by Pedro Malha. Beck, who officially took the helm in March 2024 and is best known for founding Bluemercury, will remain in an advisory role.

Malha spent more than two decades across the health care and medical device industries, most recently serving as worldwide division president and corporate officer of Abbott Laboratories, where he led the neuromodulation business. 

Prior to that, he held senior leadership roles overseeing multiple global business units at Zimmer Biomet Holdings, Abbott and Johnson & Johnson in Europe. He holds an MBA from Boston University and a bachelor of science from Bentley University.

Brent Saunders, chairman of the board, said: “Pedro is an accomplished leader with broad industry experience at leading multinational companies in the health care and medical device sectors. His ability to navigate complex global markets and build collaborative, high-performing teams makes him the right person to lead BeautyHealth into its next chapter. We are also grateful for Marla’s strong leadership during a pivotal period of transformation, which has left BeautyHealth well positioned for sustainable and profitable growth.”

Beck said: “I am incredibly proud of what we have accomplished together to strengthen BeautyHealth’s foundation and future. With the right team and strategy in place, I believe now is the right time to welcome a new CEO to lead the company into its next phase of growth. BeautyHealth has a robust pipeline of innovation and bold brand initiatives currently underway, and I look forward to watching the company continue to thrive under Pedro’s leadership.”

BeautyHealth reported net sales of $78.2 million for the second quarter, a decrease of 13.7 percent compared to the prior year that was due to lower delivery systems net sales.